ZULLO, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 3.107
AS - Asia 2.403
EU - Europa 1.082
SA - Sud America 450
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 7.095
Nazione #
US - Stati Uniti d'America 3.041
SG - Singapore 1.195
IT - Italia 572
CN - Cina 518
BR - Brasile 362
IN - India 244
VN - Vietnam 220
DE - Germania 141
GB - Regno Unito 87
HK - Hong Kong 62
FI - Finlandia 38
CA - Canada 37
SE - Svezia 36
AR - Argentina 35
NL - Olanda 31
FR - Francia 25
BD - Bangladesh 23
TR - Turchia 23
MX - Messico 22
RU - Federazione Russa 21
ID - Indonesia 20
IQ - Iraq 20
ES - Italia 17
GR - Grecia 17
PL - Polonia 16
UA - Ucraina 16
CO - Colombia 13
EE - Estonia 13
ZA - Sudafrica 13
EC - Ecuador 11
JP - Giappone 10
CH - Svizzera 9
CL - Cile 9
MA - Marocco 9
VE - Venezuela 9
IR - Iran 8
PH - Filippine 8
EG - Egitto 7
RO - Romania 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
JO - Giordania 6
DZ - Algeria 5
KE - Kenya 5
PK - Pakistan 5
PY - Paraguay 5
CZ - Repubblica Ceca 4
IE - Irlanda 4
IL - Israele 4
LB - Libano 4
LT - Lituania 4
MY - Malesia 4
RS - Serbia 4
ET - Etiopia 3
KR - Corea 3
NP - Nepal 3
PE - Perù 3
UY - Uruguay 3
AU - Australia 2
BY - Bielorussia 2
EU - Europa 2
GH - Ghana 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
MD - Moldavia 2
NO - Norvegia 2
SN - Senegal 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HU - Ungheria 1
LI - Liechtenstein 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.095
Città #
San Jose 765
Singapore 426
Ashburn 333
Chandler 234
Santa Clara 218
Bengaluru 185
Hefei 185
Dallas 172
Milan 164
Munich 116
Princeton 104
Lawrence 103
Beijing 86
Ho Chi Minh City 82
Hong Kong 60
London 56
Chicago 55
Los Angeles 52
Rome 47
Hanoi 38
São Paulo 37
Wilmington 36
Turku 31
Catanzaro 29
Naples 22
New York 21
Boardman 20
The Dalles 20
Chennai 16
Da Nang 16
Montreal 16
Phoenix 16
Warsaw 15
Thessaloniki 14
Stockholm 13
Belo Horizonte 11
Boston 11
Hanover 11
Orem 11
Rio de Janeiro 11
Shanghai 11
San Francisco 10
Brooklyn 9
Columbus 9
Des Moines 9
Amsterdam 8
Baghdad 8
Biên Hòa 8
Brasília 8
Haiphong 8
Mexico City 8
Ottawa 8
Buffalo 7
Campinas 7
Charlotte 7
Hải Dương 7
Jakarta 7
Johannesburg 7
Pune 7
Quito 7
Zurich 7
Amman 6
Ankara 6
Bologna 6
Florence 6
Lecce 6
Manchester 6
Seattle 6
Tokyo 6
Atlanta 5
Buenos Aires 5
Casablanca 5
Dhaka 5
Elk Grove Village 5
Helsinki 5
Palhoça 5
San Nicola Manfredi 5
Thái Bình 5
Vienna 5
Washington 5
Abu Dhabi 4
Bari 4
Bogotá 4
Can Tho 4
Council Bluffs 4
Córdoba 4
Feira de Santana 4
Fortaleza 4
Frankfurt am Main 4
Madrid 4
Nairobi 4
New Delhi 4
Ninh Bình 4
Norwalk 4
Palermo 4
Robbiate 4
Santo André 4
Spokane 4
Torre del Greco 4
Turin 4
Totale 4.208
Nome #
A NEW MODEL TO PREOPERATIVELY RULE OUT THE RISK OF SARCOMA IN PATIENTS AFFECTED BY UTERINE MASS: THE UTERINE MASS MAGNA GRAECIA (UMG) RISK SCORE 329
Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355) 129
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges 105
Clinics and pathology of Krukenberg Tumor: a systematic review and meta-analysis. 87
A New Algorithm To Predict Ovarian Age Combining Clinical, Biochemical and 3D-Ultrasonographic Parameters. Preliminary Results 83
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 79
DJ-1 in Endometrial Cancer: A Possible Biomarker to Improve Differential Diagnosis Between Subtypes. 76
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer. 71
The genetics of non-syndromic primary ovarian insufficiency: A systematic review 71
Relugolix for the treatment of uterine fibroids 68
Routine vaccinations during pregnancy: women knowledge and attitude during COVID-19 pandemic era, an Italian survey 67
When more is not better: 10 'don'ts' in endometriosis management. An ETIC* position statement 66
A new algorithm to predict ovarian age combining clinical, biochemical and 3D-ultrasonographic parameters 64
Endometriosis shows no impact on the euploid blastocyst rate per cohort of inseminated metaphase-II oocytes: A case-control study 64
OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters 63
Influence of COVID-19 pandemic on the psychological status of infertile couples 63
Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian study 63
Periostin and implantation: a new biomarker of embryo-endometrial cross talk 62
A Versatile Mechatronic Tool for Minimally Invasive Surgery 62
DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer. 62
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 62
'Guess who'? An Italian multicentric study on pigmentation traits prevalence in endometriosis localizations 60
Multiple bilateral ovarian teratoma in a young woman presenting with acute abdomen and ovarian torsion: lesson learned 60
The genetics of non-syndromic primary ovarian insufficiency: A systematic review 59
Being an obstetrics and gynaecology resident during the COVID-19: Impact of the pandemic on the residency training program 59
Similar miRNomic signatures characterize the follicular fluids collected after follicular and luteal phase stimulations in the same ovarian cycle 58
A New Combined Laparoscopic-Vaginal Lateral Suspension Procedure for the Treatment of Pelvic Organ Prolapse 58
Deep Myometrial Infiltration of Endometrial Cancer on MRI: A Radiomics-Powered Machine Learning Pilot Study 56
OC01. 05: A new algorithm to predict ovarian age combining clinical, biochemical and 3D‐ultrasonographic parameters 55
Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 55
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma 53
"Better late than never but never late is better", especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis 53
Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis 53
Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly at neurosonography: A multicenter study 53
[Use of progesterone-releasing intra-uterine system in menhorragia relapse prevention after laparoscopic myomectomy]. FT Impiedo della spirale medicate al progesterone nella prevenzione delle recidive menorragiche dopo miomectomia laparoscopica. 52
Obturator nerve injury during gynecological surgery: Our experience 52
Successful Vaginal Delivery after Induction of Labour in a Patient Treated for Non-Hodgkin's Lymphoma of the Cervix: A Case Report and Literature Review 52
Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer 52
Adhesion barriers in laparoscopic myomectomy: Evidence from randomized clinical trials 51
CIN 2 in childbearing-age women: may colposcopy help in choosing the proper management? 48
Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 infection 47
Cervical elastography using E-cervix for prediction of preterm birth in singleton pregnancies with threatened preterm labor. 47
Antenatal cardiotocography with and without computer analysis in high-risk pregnancy: a randomized clinical trial 47
Risk-reducing salpingectomy as a new and safe strategy to prevent ovarian cancer 46
Third Trimester Myocardial Performance Index in Fetuses from Women with Hyperglycemia in Pregnancy: A Systematic Review and Meta-Analysis 46
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 46
Pregnancy and perinatal outcomes of early vs late selective termination in dichorionic twin pregnancy: systematic review and meta-analysis 45
Perinatal and obstetric outcomes in singleton pregnancies following fresh versus cryopreserved blastocyst transfer: a meta-analysis 45
In-bag manual versus uncontained power morcellation for laparoscopic myomectomy 45
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome 45
Invasive prenatal diagnosis during COVID-19 pandemic. 45
p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP) 45
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 44
Placental dysfunction in uncomplicated and complicated intrauterine growth restriction by preeclampsia and neonatal outcome 44
Maternal and perinatal complications according to maternal age: A systematic review and meta-analysis 44
Intrahepatic persistent fetal right umbilical vein: a retrospective study 44
Leuprolide acetate depot plus high-dose raloxifene hydrochloride before and after surgery for recurrent vaginal aggressive angiomyxoma: a case report. 43
Immunohistochemical assessment of AURKA expression in ovarian serous carcinoma may be a new prognostic tool for therapy 43
Psychological impact of coronavirus disease 2019 in pregnant women 43
Cervical pessary in singleton gestations with arrested preterm labor: a randomized clinical trial 43
An integrated approach based on advanced CTG parameters and Doppler measurements for late growth restriction management 43
First trimester ultrasound features of X-linked Opitz syndrome and early molecular diagnosis: case report and review of the literature 43
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 43
Ki67 as a prognostic marker in uterine leiomyosarcoma: A quantitative systematic review. 43
Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis 43
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes 42
Similar miRNomic signatures characterize the follicular fluids collected after follicular and luteal phase stimulations in the same ovarian cycle 41
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: A focus on the quality of life 41
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome 41
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 40
Hysteroscopic Intact Removal of Angular and Caesarean Scar Pregnancy: A Novel and Markedly Less Invasive Surgical Treatment 40
Histological Prognostic Factors of Endometrial Cancer in Patients with Adenomyosis: A Systematic Review and Meta-Analysis 39
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes 39
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 38
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review 38
Obstetric A&E unit admission and hospitalization for obstetrical management during COVID-19 pandemic in a third-level hospital of southern Italy. 38
Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma 38
Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma 37
The Fallopian Tube in the 21st Century: When, Why, and How to Consider Removal. 37
Use of routine ureteral stents in cesarean hysterectomy for placenta accreta 37
Gardnerella vaginalis and Trichomonas vaginalis infections as risk factors for persistence and progression of low-grade precancerous cervical lesions in HIV-1 positive women 37
Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women 36
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 36
Association between lymphadenopathy after toxoplasmosis seroconversion in pregnancy and risk of congenital infection 36
Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature 35
Clinicopathological Features Associated with Microsatellite Instability/Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Quantitative Systematic Review 35
Post-liquefaction normospermic human semen behaves as a weak-gel viscoelastic fluid 35
Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up 35
Adiponectin levels in women with polycystic ovary syndrome 35
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 35
Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and Meta-analysis 35
Presacral neurectomy for surgical management of pelvic pain associated with endometriosis: A descriptive review 34
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 34
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination 34
Does raloxifene inhibit the growth of uterine fibroids? [10] (multiple letters) 34
Risk of Recurrence in Uterine Leiomyoma with Bizarre Nuclei: A Systematic Review and Meta-Analysis 34
Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines 34
Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data. 34
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 32
Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial 32
Totale 5.225
Categoria #
all - tutte 70.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 19 4 0
2021/2022251 5 1 5 21 5 15 63 45 19 45 22 5
2022/2023829 209 46 35 27 74 51 3 83 181 43 54 23
2023/2024537 78 80 58 56 33 96 17 18 13 18 38 32
2024/20251.823 243 77 55 76 91 238 54 40 273 62 228 386
2025/20263.732 224 463 333 558 490 173 490 183 593 225 0 0
Totale 7.285